ELN gets 3.3B in royalties from BIIB, says will use it to buy small to medium biotech company's
Shorts better be very carful with their short positions in company's just like a THLD, now that it's known that ELN has all of this money and is looking to be buying out many biotech's and could be poking their nose around in this area of the biotech sector in the near future.
ELN is not likely to be looking at a purchase of THLD----as THLD has already got a serious girlfriend in Germany. The only way this could change would be be for MerckAga or THLD to untangle their relationship--which is not on today's map. ELN's $4 bil warchest will give them some flexibility to make purchases/in-license products but that probably won't happen here as THLD has already sold some of their potential marketing rights. Even thought THLD gets little-to-no respect as a company it likely will not be taken over by anyone until they show product breakthroughs which will take time to bear fuit.